Search results for "Coronavirus disease 2019"

showing 10 items of 953 documents

COVID-19 and tuberculosis - threats and opportunities

2020

Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakEconomic growthTuberculosisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralInternational Health RegulationsGlobal HealthInternational Health RegulationsBetacoronavirusPandemicGlobal healthMedicineHumansPandemicsTuberculosis PulmonaryHealth Services Needs and Demandbusiness.industryCoinfectionSARS-CoV-2COVID-19medicine.diseaseCoronavirusInfectious DiseasesCommunicable Disease ControlbusinessCoronavirus InfectionsCoronavirus Infections
researchProduct

Helmet continuous positive airway pressure and prone positioning: A proposal for an early management of COVID-19 patients

2020

In late December 2019, clusters of patients with interstitial pneumonia of unknown cause were reported by some local health facilities in Wuhan (China). The Chinese Centre for Disease Control conducted an epidemiologic and etiologic investigation, leading to the identification of a novel coronavirus (SARS-CoV-2).1, 2 On March 11th, the World Health Organization (WHO) declared the novel coronavirus disease (COVID-19) a pandemic. In the area of Wuhan, COVID-19 mainly affected male patients (around 60%), with a median age of about 50 years; 40% of patients developed Acute Respiratory Distress Syndrome (ARDS) 5% requiring intensive care. The mortality rate was around 2%.3, 4 However, Grasselli …

Pulmonary and Respiratory Medicine2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralcoronavirusArticlePatient PositioningPositive-Pressure RespirationBetacoronavirusPandemicmedicineHumansContinuous positive airway pressurePositive-Pressure RespirationHypoxiaLung CompliancePandemicslcsh:RC705-779Respiratory Distress SyndromeContinuous Positive Airway PressurebiologySARS-CoV-2business.industryhelmetCOVID-19lcsh:Diseases of the respiratory systembiology.organism_classificationProne positionVasoconstrictionprone positionEmergency medicineHead Protective DevicesCoronavirus InfectionsRespiratory InsufficiencybusinessBetacoronavirusCPCP COVID-19 SARS-CoV-2
researchProduct

Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave.

2022

SARS-CoV-2 pandemic has contributed to implement telemedicine, allowing clinicians to follow the patient remotely, therefore minimizing the risk of any exposure to positive COVID-19 patients. We summarize the approaches adopted to treat and monitor severe asthmatic patients during the lockdown phase of the pandemic. Our experience supports the strategy that every effort should be made to minimize patient contact with the health-care system, planning a pathway that allows patients to receive appropriate medical care and continue the biological therapies, thus preventing the loss of disease control and acute severe exacerbations.

Pulmonary and Respiratory MedicineCOVID-19 Health-care management Respiratory symptoms Severe asthmasevere asthmamedicine.medical_specialtyTelemedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaSettore MED/10 - Malattie Dell'Apparato RespiratorioPhase (combat)ArticlePandemicmedicineAsthmatic patientHumansPharmacology (medical)Intensive care medicinehealth-care managementPandemicsbusiness.industrySARS-CoV-2Biochemistry (medical)Patient contactrespiratory symptomsCOVID-19AsthmaCommunicable Disease ControlbusinessPulmonary pharmacologytherapeutics
researchProduct

A Key to Unlocking the Mysteries of COVID-19 Pulmonary Sequelae: Are We There?

2022

N/A

Pulmonary and Respiratory MedicineCoronavirus disease 2019ScoreCoronavirus disease 2019 Pulmonary sequelae ScorePulmonary sequelaeSettore MED/10 - Malattie Dell'Apparato RespiratorioRespiration
researchProduct

Prioritizing care for severe asthma during SARS-CoV-2 pandemic

2021

Background Almost the entire World is experiencing the Coronavirus-Disease-2019 (COVID-19) pandemic, responsible, at the end of May 2020, of more than five million people infected worldwide and about 350,000 deaths. In this context, a deep reorganization of allergy clinics, in order to ensure proper diagnosis and care despite of social distancing measures expose, is needed. Main text The reorganization of allergy clinics should include programmed checks for severe and poorly controlled patients, application of digital medicine service for mild-to-moderate disease in well-controlled ones, postponement of non urgent diagnostic work-ups and domiciliation of therapies, whenever possible. As far…

Pulmonary and Respiratory MedicineDigital medicine service2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)AllergyPandemicbusiness.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaMEDLINECOVID-19ReviewBiologicalsasthmaSettore MED/10 - Malattie Dell'Apparato RespiratorioVirologyTelemedicineArticlePandemicHome deliveryMedicineImmunotherapybusiness
researchProduct

Effectiveness and safety of a new helmet CPAP configuration allowing tidal volume monitoring in patients with COVID-19.

2021

Abstract Background High generated tidal volumes (Vt) have been correlated with higher risk of self-induced lung injury and worse clinical outcome. This study aimed to evaluate the effectiveness and safety of a new helmet continuous positive airway pressure delivered (h-CPAP) configuration allowing Vt monitoring in patients affected by COVID-19. Methods This prospective observational study was performed in the respiratory intermediate care unit of University Hospital in Turin, Italy, between March 24th, and June 15th, 2020. Included patients were treated with CPAP via a single-limb intentional leak configuration by a turbine-driven ventilator, provided with a dedicated patch. Effectiveness …

Pulmonary and Respiratory MedicineLeakTidal volume monitoringmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)List of abbreviations: ARF Acute respiratory failuremedicine.medical_treatmentLung injuryTidal volumeVt Tidal volumeCPAPMedicineIn patientContinuous positive airway pressureTidal volumeHelmetCPAP Continuous positive airway pressureRICU Respiratory intermediate care unitbusiness.industryCOVID-19ICU Intensive care unitEmergency medicineHFNT High flow nasal therapyObservational studyOriginal ArticleTDVs turbine-driven ventilatorsbusinessPulmonology
researchProduct

Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study

2021

The outbreak of severe acute respiratory syndromecoronavirus-2, the cause of coronavirus disease 2019 (COVID-19) in December 2019 represented a global emergency accounting for more than 2.5 million deaths worldwide.1 It has had an unprecedented influence on cardiac surgery internationally, resulting in cautious delivery of surgery and restructuring of services.2 Understanding the influence of COVID-19 on patients after cardiac surgery is based on assumptions from other surgical specialties and single-center studies. The COVIDSurg Collaborative conducted a multicenter cohort study, including 1128 patients, across 235 hospitals, from 24 countries demonstrating perioperative COVID-19 infection…

Pulmonary and Respiratory MedicineMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)complication.ArticleNOCohort Studiesoutcomes; complications; following cardiac surgery; coronavirus disease 2019Postoperative ComplicationsCardiovascular Diseases; Cohort Studies; Female; Humans; Male; Middle Aged; SARS-CoV-2; COVID-19; Cardiac Surgical Procedures; Postoperative ComplicationsInternal medicineCardiovascular DiseasemedicineCardiac Surgical ProcedureHumansIn patientCardiac Surgical ProceduresLS7_4business.industrySARS-CoV-2COVID-19Middle AgedCardiac surgeryCardiovascular DiseasesoutcomeSurgeryFemaleCohort StudieCardiology and Cardiovascular Medicinebusinesscardiac surgery[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyCohort studyHuman
researchProduct

Length of remdesivir treatment in patients with severe COVID-19

2021

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has caused more than 96 million cases and over 2 million deaths worldwide as of January 21, 2021. As the crisis continues, the scientific community, institutions and pharmaceutical industries are striving to find effective therapies to prevent or treat the disease. Remdesivir (GS-5734) was early identified as an option.

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)RC705-779Journal Clubbusiness.industry4Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RemdesivirMEDLINEExpert Opinion03 medical and health sciencesRegimenDiseases of the respiratory system0302 clinical medicine030228 respiratory systemSAFERMedicineIn patient030212 general & internal medicinebusinessBit (key)Breathe
researchProduct

Comments on “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations” by D'Amato et al

2021

We have read with interest the letter from D’Amato et al. entitled “Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations”....

Pulmonary and Respiratory MedicinePediatricsmedicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryHome therapySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)COVID-19030204 cardiovascular system & hematologyLMWH03 medical and health sciences0302 clinical medicinemedicineSteroidsbusinessLetter to the EditorHome therapy030215 immunology
researchProduct

Tidal volume and helmet: Is the never ending story coming to an end?

2021

Noninvasive ventilation (NIV) has been increasingly used in acute care setting with various indications, but its use in patients with acute hypoxemic respiratory failure (AHRF) is controversial. In this setting, reliable monitoring of Vt and unintentional leaks is of the utmost importance. The aim of this article is to describe the importance of tidal volume measurement in the context of AHRF treated with NIV.

Pulmonary and Respiratory Medicinelcsh:RC705-7792019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:Diseases of the respiratory systemEmergency medicinemedicineTidal VolumeHumansNoninvasive ventilationHead Protective DevicesbusinessNoninvasive ventilationTidal volumePulmonology
researchProduct